PRELIMINARY SCIENTIFIC PROGRAMME

• Genetics and kidney disease
- Renal function, albuminuria and CKD: insights from genome-wide association studies
Carsten Boger, Regensburg, Germany
- Patho-physiology and progression of APKD
Olivier Devuyst, Brussels, Belgium
- Genetic defects, magnesium handling and systemic consequences
Shazia Adalat, London, UK
- Epigenetics and kidney disease
Speaker to be confirmed

• Complement and the kidney
- Infections, complement activation and renal diseases
Mohamed Daha, Leiden, the Netherlands
- Thrombotic microangiopathies: evolving concepts
Fadi Fakhouri, Nantes, France
- Innovative strategies for complement inhibition
Marina Noris, Bergamo, Italy

• Growth factors, hormones and the kidney
- Metabolic role of natriuretic peptide – is it important for renal failure?
Max Lafontan, Toulouse, France
- The Renin Angiotensin System and its inhibition
- Speaker to be confirmed
- Adipokine signaling and the kidney
Peter Barany, Stockholm, Sweden
- Vasopressin as a risk factor for CKD
Ron T. Gansevoort, Groningen, the Netherlands

• Podocytes and proteinuria
- Signaling in podocytes and the pathogenesis of proteinuria
Thomas Benzing, Cologne, Germany
- The molecular link between the immune systemand podocyte disease in idiopathic nephrotic syndrome
Djillali Sahali, Paris, France
- MIF receptor in podocyte injury of diabetic nephropathy
Alberto Ortiz, Madrid, Spain
- Autocrine and paracrine VEGF-signaling in podocytes
Mario Schiffer, Hanover, Germany

• Proteomics, functional genomics and metabolomics as a tool to investigate renal disease
- Proteomics in renal failure and renal disease
Harald Mischak, Hanover, Germany
- Transcriptional platforms for biomarker development
Gerjan Navis, Groningen, the Netherlands
- Metabolomics for biomarker detection
Joachim Jankowski, Berlin, Germany

• Inflammation and the kidneys
- Modulating infl ammation in renal diseases
Jesus Egido, Madrid, Spain
- Toll-like receptors in renal infl ammation
Hans-Joachim Anders, Munich, Germany
- Heat shock proteins and the kidney
Ewen Harrison, Edinburgh, UK
- Potassium channels – master switch of renal fibrosis?
Paolo Mene, Rome, Italy

• Auto-immunity and tolerance
- Apoptotic blebs and apoptosis-modifi ed autoantigens trigger autoimmunity in Systemic Lupus Erythematosus: new leads for therapy
Johan van der Vlag, Nijmegen, The Netherlands
- Anti-B-cell treatment in vasculitis and lupus
David Jayne, Cambridge, UK
- New autoantibodies in vasculitis
Speaker to be confirmed
- Costimulatory blockade in vasculitis and lupus
Alan Salama, London, UK

• Angiogenesis, vasculogenesis and lymphangiogenesis
- Salt in space
Speaker to be confirmed
- Lymphangiogenesis in transplantation
Dontscho Kerjaschki, Vienna, Austria
- Angiogenesis in peritoneal dialysis
Speaker to be confirmed
- Therapeutic inhibition of angiogenesis and the kidney
Christian Hugo, Dresden, Germany

Clinical nephrology

• The kidney in pregnancy
- News in the pathogenesis and treatment of preeclampsia
Jean-Michel Foidart, Liege, Belgium
- Pregnancy in CKD
Speaker to be confirmed
- Pregnancy and Lupus Nephritis. Predictors of foetal and maternal outcomes
Enrico Imbasciati, Milano, Italy
- Asymptomatic bacteriuria and urinary tract infection in pregnancy
Fiona Smaill, Hamilton, Canada

• The kidneys and specific conditions
- Viruses and antiviral treatment as causes of chronic kidney damage in native kidneys
Michel Jadoul, Brussels, Belgium
- Medical treatment of primary renal malignancies
Speaker to be confirmed
- Chronic kidney disease in the elderly
Elke Schaeffner, Berlin, Germany

• IgA nephropathy
- Histologic markers indicating the need for therapeutic intervention in IgA nephropathy
Ian Roberts, Oxford, UK
- Is a legacy effect possible for IgA nephropathy?
Rosanna Coppo, Turin, Italy
- Genomics in IgA nephropthy
Francesco Paolo Schena, Bari, Italy
- Recurrence of IgA nephropathy after kidney transplantation
Jurgen Floege, Aachen, Germany

• Diabetic nephropathy
- Expression profiles in diabetic nephropathy
Clemens Cohen, Zurich, Switzerland
- Novel mediators in the progression of diabetic nephropathy
Catherine Godson, Dublin, Ireland
- AGE’s, RAGE and diabetic nephropathy
Speaker to be confirmed
- How to slow down the progression of diabetic nephropathy
Speaker to be confirmed

• The kidney in paraproteinemia
- Renal complications of myeloma and related disorders: an update
Pierre Ronco, Paris, France
- Renal involvement in essential mixed cryoglobulinemia
Dario Roccatello, Turin, Italy
- Treatment of myeloma cast nephropathy with high cut-off dialysis
Colin Hutchison, Birmingham, UK
- Treatment and monitoring of AL-amyloidosis: the evolving story
Speaker to be confirmed

• Metabolic syndrome and the kidney
- Definition of the metabolic syndrome
Speaker to be confirmed
- Metabolic syndrome and link with CVD
Mimi Giri, Ghent, Belgium
- Calorie excess and CKD
Kumar Sharma, La Jolla, USA

• ERA-EDTA Working Group Immunonephrolog

Dialysis

• Protein energy wasting
- Uremic toxins, a neglected source of infl ammation
Pieter Evenepoel, Louvain, Belgium
- Assessment
Speaker to be confirmed
- Biomarkers and surrogates of PEW and impact on CKD outcomes
Kamyar Kalantar Zadeh, Los Angeles, USA

• Dialysis adequacy
- What is “adequacy of dialysis”?
Peter J. Blankenstijn, Utrecht, the Netherlands
- Achieving the balance of adequate PD prescription and preservation of RRF
Simon J. Davies, Stoke-on-Trent, UK
- Preservation of the peritoneal membrane in PD
Janusz Witowski, Warsaw, Poland

• Alternative strategies to improve dialysis quality
- Dialysate purity
Ralf Schindler, Berlin, Germany
- Convection with conviction and addiction
Bernard Canaud, Montpellier, France
- Daily and long nocturnal dialysis
Speaker to be confirmed
- The Wearable Artifi cial Kidney: a paradigm change in the treatment of ESRD
Victor Gura, Los Angeles, USA

• Anaemia
- CKD anaemia treatment: a look at the future
Francesco Locatelli, Lecco, Italy
- Hematide: a new era of ESA therapy, or more of he same?
Iain C. Macdougall, London, UK
- Hepcidin and renal anaemia
Jolanta Malyszko, Bialystok, Poland
- HIF stabilizers and their potential in kidney disease
Kai-Uwe Eckardt, Erlangen, Germany

• CKD/MBD
- Vitamin D and its analogues: impact on clinical status and outcomes
Mariano Rodriguez, Cordoba, Spain
- The link between CKD/MBD and blood vessels
Markus Ketteler, Coburg, Germany
- Osteoporosis, adynamic bone disease and CKD
Jorge B. Cannata Andia, Oviedo, Spain
- Physiology of renal P-handling and therapeutic consequences
Carsten Wagner, Zurich, Switzerland

• Patient support to improve outcomes
- Medical aspects of depression in dialysis
Francesca Mallamaci, Reggio Calabria, Italy
- Exercise rehabilitation outcomes in CKD patients
Evangelia Kouidi, Thessaloniki, Greece
- Multidisciplinary care models
Adeera Levin, Vancouver, Canada
- Helping in the choice between peritoneal dialysis and haemodialysis
A. Rodrigues, Porto, Portugal

• EUTox Working Group

Transplantation

• Transplantation tolerance: where do we stand?
- Current status
Jean-Paul Soulillou, Nantes, France
- The “Reprogramming immune system for establishing tolerance (RISET)” project
Speaker to be confirmed
- Transplantation tolerance from bench to bedside
Hans-Dieter Volk, Berlin, Germany
- Tolerance fingerprints in transplant biopsies
Martin Zeier, Heidelberg, Germany

• How to improve the success of your transplant programme
- Molecular predictors of outcome
Ondrej Viklicky, Prague, Czech Republic
- Prevention and treatment of BKV nephropathy
Petra Reinke, Berlin, Germany
- Prevention of delayed graft function
Speaker to be confirmed
- Post transplantation cardiovascular disease
Speaker to be confirmed

• New immunosuppressive agents
- Bortezomib and Eculizumab
Speaker to be confirmed
- Costimulatory blockade in renal transplantation: belatacept
Josep Grinyo, Barcelona, Spain
- Rituximab indications and side eff ect after kidney transplantation
Nassim Kamar, Toulouse, France
- Alemtuzumab
Dela Golshayan, Lausanne, Switzerland

• Innovations in transplantation immunology
- Detection and control of humoral alloreactivity
Georg Bohmig, Vienna, Austria
- Immunogenetics
Speaker to be confirmed
- Th17 cells and regulation of immmune responses
Michiel Betjes, Rotterdam, the Netherlands
- Vitamin D and the immune system
Klaus Olgaard, Copenhagen, Denmark

• Resetting the standards in transplantation
- Marginal recipients: where is the red line
Bengt Fellstrom, Uppsala, Sweden
- Extended criteria donors: where is the limit
Ulrich Frei, Berlin, Germany
- Living Donor exchange programme
Willem Weimar, Rotterdam, the Netherlands

• Renal biopsies
- Protocol biopsy – pro
Daniel Abramowicz, Brussels, Belgium
- Protocol biopsy – con
Speaker to be confirmed
- Update on Banff 07 criteria
Evelyne Lerut, Louvain, Belgium
- Direct effect of calcineurin inhibitors and corticosteroids on podocytes
Alain Meyrier, Paris, France

Vascular disease and kidneys

• Risk factors for CVD and CKD (1)
- Dyslipidemia
Christoph Wanner, Wurzburg, Germany
- Is uric acid a risk facotr for CVD and CKD? A critical analysis
Tomas Berl, Denver, USA
- Obesity as a risk factor for CVD and progression of CKD
Mark Sarnak, Boston, USA
- Hypertension and its correct assessment
Johannes Mann, Munich, Germany

• Risk factors for CVD and CKD (2)
- Endothelium “senses” salt
Hans Oberleithner, Munster, Germany
- Is there a role for vitamin K supplementation in preventing uremic vascular calcifi cation?
Georg Schlieper, Aachen, Germany
- Salt and the kidney
Eberhard Ritz, Heidelberg, Germany
- Anaemia as a risk factor
Tilman Drueke, Paris, France

• Sympathetic overactivity: new evidence in CKD and beyond
- Genetic modulation of sympathetic activity and blood pressure: the Phosducin story
Nadine Beetz, Freiburg, Germany
- Sympathatic overactivity in CKD: mechanisms and clinical implications
Kerstin Amann, Erlangen, Germany
- Biomarkers of sympathetic activity and cardiovascular risk in CKD
Carmine Zoccali, Reggio Calabria, Italy

• Cardiovascular complications in CKD
- Atrial fibrillation and oral anticoagulants
Speaker to be confirmed
- Percutaneous coronary interventions?
Stefan Anker, Berlin, Germany
- Aneurysms of the abdominal aorta
Speaker to be confirmed
- Sudden death in chronic kidney disease - a neglected priority for intervention
David Goldsmith, London, UK

• Vascular dysfunction - In collaboration with ESH
- Endothelial damage
Ton J. Rabelink, Leiden, the Netherlands
- Does uraemia cause vascular dysfunction?
Philippe Brunet, Marseille, France
- Arterial stiff ness in adult patients with chronic kidney diseases
Pierre Boutouyrie, Paris, France
- Heart involvement in CKD: from large arteries stiff ness to microvascular disease
Adrian Covic, Iasi, Romania

• Cardiovascular Working Goup (EURECAM) - In collaboration with ISH

• Bone cross talks
- Bone-vessel-adipocyte crosstalk with a new bone imaging technique
Denis Fouque, Lyon, France
- The osteocyte revisited
Speaker to be confirmed
- The bone and the arterial system
Gerard M. London, Paris, France
- Adipokines, fat and bone mass – what are the links?
Peter Stenvinkel, Stockholm, Sweden

• Vascular calcification
- New insights on the mechanisms of vascular calcification
Rukshana Shroff, London, UK
- Bio-markers for vascular calcification
Jean-Paul Cristol, Montpellier, France
- Vascular calcifi cation and clinical outcomes in patients with CKD 3-5 (non D)
Domenico Russo, Naples, Italy
- Therapeutic strategies
Ziad Massy, Amiens, France

General nephrology

• History of nephrology
- The kidneys and their diseases in the 18th century
Natale G. De Santo, Naples, Italy
- History of ERA-EDTA
Speaker to be confirmed
- The past is prologue: masterminds of Nephrology in the early 20th century
Joerg Hans Vienken, Bad Homburg, Germany
- Contribution of Jan Brod to nephrology
Ivan Rychlik, Prague, Czech Republic

• Ethical issues
- The Istanbul Declaration on organ sales
Speaker to be confirmed
- Dialysis vs. conservative treatment in the very old
Nada Dimkovic, Belgrade, Serbia
- In good conscience – safely withholding dialysis in the elderly
Indranil Dasgupta, Birmingham, UK
- Ethical issues related to quality of life in dialysis patients
Istvan Mucsi, Budapest, Hungary

• ERBP
• KDIGO
• DOPPS
• ERA-EDTA Registry

EDUCATIONAL MEETING

EURECA-m
(EUropean REnal and CArdiovascular Medicine)

LITERATURE UPDATES

- AKI
Miet Schetz, Louvain, Belgium
- Glomerulonephritis
John Feehally, Leicester, UK
- Progression of kidney failure
Vladimir Tesar, Prague, Czech Republic
- Haemodialysis
Speaker to be confirmed
- Peritoneal dialysis
Olof Heimburger, Stockholm, Sweden
- What is new in kidney transplantation
Gultekin Suleymanlar, Antalya, Turkey

LATE BREAKING CLINICAL TRIALS

PRE-CONGRESS CME COURSES

Blood pressure and haemodynamic stability in dialysis
Chair: Jeroen Kooman, Maastricht, the Netherlands

Clinical pathological conference
Chair: Sandrine Florquin, Amsterdam, the Netherlands

Diagnostic approach to kidney injury
Chairs: Wim Van Biesen, Ghent, Belgium and Ron T. Gansevoort, Groningen, the Netherlands

New imaging options for cardio-renal patients
Chair: Rudolf Wuthrich, Zurich, Switzerland

Vascular access
Chair: Jan Tordoir, Maastricht, the Netherlands

Treatment of glomerulonephritis
Chair: Alain Meyier, Paris, France

Epidemiological methodology and statistics
Chair: Kitty Jager, Amsterdam, the Netherlands

Renal artery stenosis
Chair: Andrzej Wiecek, Katowice, Poland

EDUCATIONAL SYMPOSIUM

How to write a paper?
Raymond Vanholder, Ghent, Belgium

How to write a grant application?
Heini Murer, Zurich, Switzerland

Download Preliminary Programme in PDF

For further information visit:
www.eraedta2011.org